Vanguard Portfolio Management’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.3M Buy
2,297,581
+136,482
+6% +$1.71M ﹤0.01% 1853
2026
Q2
$31.9M Buy
2,161,099
+698,293
+48% +$4.82M ﹤0.01% 1844
2026
Q1
$6.19M Buy
+1,462,806
New +$6.54M ﹤0.01% 2262

Other funds holding SLS

Vanguard Portfolio Management's SLS Position: Q3 2026 in Review

Vanguard Portfolio Management increased its SELLAS Life Sciences (SLS) stake by 6.3% in Q3 2026, buying an estimated $1.71M and bringing the position to 2,297,581 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

Vanguard Portfolio Management first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.9M in Q2 2026. 168 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Vanguard Portfolio Management held 2,297,581 shares of SELLAS Life Sciences worth $28.3M as of Q3 2026.
  • Vanguard Portfolio Management bought 136,482 SELLAS Life Sciences shares in Q3 2026, an estimated $1.71M.
  • SELLAS Life Sciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1853 holding.
  • Vanguard Portfolio Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's SELLAS Life Sciences position peaked at $31.9M in Q2 2026.
  • 168 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.